SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

PB Fintech’s arm gets nod to make further investment in Visit Health

01 Dec 2021 Evaluate

PB Fintech’s fully-owned subsidiary -- Docprime Technologies has received approval for further investment approximately of Rs 10.81 crore in healthcare and wellness services provider Visit Health (VHPL). In lieu, VHPL will issue 1,44,511 compulsorily convertible debentures (CCDs) of Rs 748 each to Docprime. Docprime is making further investment in Visit Health to acquire a minority stake as part of strategic investment. The board of directors of the company approved the proposal at a meeting held on November 30, 2021.

The company has built India’s largest online platform for insurance and lending products leveraging the power of technology, data and innovation. It provides convenient access to insurance, credit and other financial products and aim to create awareness amongst Indian households about the financial impact of death, disease and damage.

PB Fintech Share Price

1600.65 47.35 (3.05%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×